Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Knight

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
FEBS Letters|January 1, 2009
Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injuryTiziano M Scarabelli, Sofia Mariotto, Safwat Abdel-Azeim, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
Brain : a Journal of Neurology|September 27, 2012
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 yearsKatharina Stoeck, Pascual Sanchez-Juan, Joanna Gawinecka, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Kidney International Reports|September 12, 2022
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference ProceedingsConnie M Rhee, Dawn Edwards, Rebecca S Ahdoot, et al.
Human Genetics|September 28, 2005
Genetic prion disease: the EUROCJD experienceGábor G Kovács, Maria Puopolo, Anna Ladogana, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2020
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine ProjectKatherine R Tuttle, Richard Knight, Paul S Appelbaum, et al.
JHLT Open|July 21, 2025
Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experienceKhush Patel, Zoe H Tu, Carrie Yuen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
The Lancet. Neurology|September 19, 2020
Potential human transmission of amyloid β pathology: surveillance and risksElsa Lauwers, Giovanna Lalli, Sebastian Brandner, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
FEBS Letters|January 1, 2009
Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injuryTiziano M Scarabelli, Sofia Mariotto, Safwat Abdel-Azeim, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
Brain : a Journal of Neurology|September 27, 2012
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 yearsKatharina Stoeck, Pascual Sanchez-Juan, Joanna Gawinecka, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Kidney International Reports|September 12, 2022
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference ProceedingsConnie M Rhee, Dawn Edwards, Rebecca S Ahdoot, et al.
Human Genetics|September 28, 2005
Genetic prion disease: the EUROCJD experienceGábor G Kovács, Maria Puopolo, Anna Ladogana, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2020
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine ProjectKatherine R Tuttle, Richard Knight, Paul S Appelbaum, et al.
JHLT Open|July 21, 2025
Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experienceKhush Patel, Zoe H Tu, Carrie Yuen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
The Lancet. Neurology|September 19, 2020
Potential human transmission of amyloid β pathology: surveillance and risksElsa Lauwers, Giovanna Lalli, Sebastian Brandner, et al.
Pageof 16